Filing Details

Accession Number:
0001144204-18-050965
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-26 17:45:03
Reporting Period:
2018-09-24
Accepted Time:
2018-09-26 17:45:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
910267 Titan Pharmaceuticals Inc TTNP Biological Products, (No Disgnostic Substances) (2836) 943171940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1739970 Seghi Federico Recli Via Ilio Barontini 8
Scandicci (Florence) L6 50018
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-09-24 500,000 $0.00 600,845 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The weighted average price is $0.2276 per share while the low trade price is at $0.2223 and the high trade price at $0.235.